Experts from across oncology specialties highlight research being presented at the 2026 AACR Annual Meeting.
Advertisement
Advertisement
As the 2026 AACR Annual Meeting gets into full swing, OncLive® asked key researchers for intel on the presentations and conversations at the top of their lists. We gathered exclusive insights from:
Paula R. Pohlmann, MD, MSc, PhD, a professor in the Department of Breast Medical Oncology and the Department of Investigational Cancer Therapeutics in the Division of Cancer Medicine at The University of Texas MD...
With multiple ADCs now available for use in gynecologic cancers, treatment decision-making incorporates biomarker nuances and raises sequencing questions.